Association between postnatal weight gain and need for treatment in retinopathy of prematurity

J Matern Fetal Neonatal Med. 2022 Dec;35(25):8027-8031. doi: 10.1080/14767058.2021.1940937. Epub 2021 Jun 22.

Abstract

Objective: To study the association between gestational age (GA) and weight at birth and the development of retinopathy of prematurity (ROP), and in particular the link between postnatal weight gain during the first 6 weeks and need for ROP treatment.

Material and methods: Retrospective observational study of premature infants who underwent ophthalmoscopy at Hospital Universitari Vall d'Hebron in Barcelona, Spain, between June 2017 and December 2018. We collected data on obstetric and birth characteristics, comorbidities, GA and weight at birth, and weekly weight for the first 6 weeks.

Results: Ninety patients with a mean ± SD GA of 26.87 ± 1.90 weeks and a mean birth weight of 884.29 ± 227.40 g were studied. The mean weight at 6 weeks was 1656.89 ± 478.51 g, which corresponds to a gain of 776.17 ± 298.12 g. Thirty-seven patients (41.1%) were diagnosed with ROP and nine (10%) needed treatment. Significant predictors of the need for treatment in patients with ROP were GA (p = .018) and weight at 6 weeks (p = .021). Birth weight was not significant (p = .361).

Conclusions: GA and weight gain during the first 6 weeks of life are significantly associated with the need for treatment in infants with ROP. Sex and birth weight were not significant predictors. Postnatal weight gain at 6 weeks is predictive of the need for ROP treatment.

Keywords: Retinopathy of prematurity; treatment; weight gain.

Publication types

  • Observational Study

MeSH terms

  • Birth Weight
  • Gestational Age
  • Humans
  • Infant
  • Infant, Newborn
  • Retinopathy of Prematurity* / diagnosis
  • Retinopathy of Prematurity* / epidemiology
  • Retinopathy of Prematurity* / therapy
  • Retrospective Studies
  • Risk Factors
  • Weight Gain